Company news

Avacta Group PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Change of accounting reference date

January 18, 2019

Director/PDMR Shareholdings

January 7, 2019

Avacta London Science Day

December 17, 2018

Appointment of Chief Medical Officer

December 12, 2018

Avacta (AVCT): Wake-up call for the market

December 10, 2018

Development Partnership with LG Chem Life Sciences

December 10, 2018

Avacta to Present at Major European Conference

November 12, 2018

Avacta's CTO to Present at Major US Conference

October 11, 2018

Avacta agrees Affimer reagent licensing deal

October 10, 2018

Investor Meeting and Presentation

September 21, 2018

Avacta (AVCT): Capital increase for further dev...

September 5, 2018

Results of Placing and Subscription

July 30, 2018

Proposed Placing and Subscription to raise £11.4m

July 30, 2018

Avacta (AVCT): Ground-breaking new drug conjuga...

July 30, 2018

Major Therapeutics Co-development Partnership

July 24, 2018

Avacta (AVCT): Gearing up the management team

June 26, 2018

Appointment of Non-Executive Chairman

June 11, 2018

Avacta (AVCT): In vivo expression of Affimers

May 31, 2018

Successful Outcome of Study with FIT Biotech

May 22, 2018

Avacta (AVCT): Commendable rate of progress

April 17, 2018

Avacta to Present at Investor Forum

March 29, 2018

Summary of Capital Markets Day

February 8, 2018

Avacta and OncoSec to Collaborate

January 22, 2018

HardmanResearch: Affimer Drug Conjugates a reality

January 15, 2018

Drug Development Partnership with Glythera

January 15, 2018

Capital Markets Day Notification

January 8, 2018

PDMR Dealing and Issue of Equity

January 4, 2018

Presenting at the Biotech Showcase, San Francisco

January 3, 2018

Covance to Present Affimer Data at Conference

November 15, 2017

Avacta to present at PEGS Europe

November 13, 2017

Avacta to Present at Investor Evening

November 13, 2017

Affimers in Scientific Publications

October 24, 2017

Private Shareholder Update Event

October 19, 2017

Hardman Res.: R&D accelerated to advance assets

October 16, 2017

Avacta to Present at Shares Spotlight Evening

October 12, 2017

Avacta to Present at Major US Conference

October 10, 2017

Director Dealing and Issue of Equity

October 9, 2017

Research collaboration with FIT Biotech Oy

October 5, 2017

Avacta establishes US business development team

October 2, 2017

Manchester ShareSoc Growth Company Seminar

July 4, 2017

ShareSoc Growth Company Seminar

June 5, 2017

2 Biotech's Licence Affimers for Research Use

May 22, 2017

Key Affimer Patent To Be Granted in China

May 10, 2017

Hardman Research: De-risking Moderna's partnership

May 8, 2017

Presenting at the Hardman Private Investor Forum

May 5, 2017

Avacta to Present at BioTrinity 2017

May 2, 2017

Diagnostics firm take rights to several Affimers

April 24, 2017

Avacta to Present at the Shares Spotlight Evening

April 19, 2017

Hardman Research: Another important box ticked

April 12, 2017

Results of Immunogenicity Study with Human Samples

April 3, 2017

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.